Collaborations & Alliances
Related Searches:
Filter by:
376 - 390 of 1089 results
July 12, 2011
Mylan's Matrix Laboratories Ltd. entered an expanded licensing agreement with Gilead Sciences for the rights to produce and market generic versions of three Gilead HIV/AIDS therapies, currently in late-stage development.
Read More »
July 12, 2011
Companies collaborate on second candidate for MANF-based therapeutic for the treatment of the beta cell destruction at the root of diabetes.
Read More »
July 11, 2011
Micromet has entered into a collaboration agreement with Amgen for the research of BiTE antibodies against three undisclosed solid tumor targets.
Read More »
July 8, 2011
Onconova Therapeutics and SymBio Pharmaceuticals will collaborate to develop and commercialize rigosertib in Japan and Korea.
Read More »
July 7, 2011
Evotec in three-year discovery collaboration with UCB for CNS disorders
Read More »
July 6, 2011
Biogen Idec has selected Unilabs to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV.
Read More »
July 6, 2011
Cambrex Corp. and Tillotts Pharma have entered into a development and commercialization agreement using a new mesalamine-based (5-ASA) technology for an Inflammatory Bowel Disease (IBD) treatment.
Read More »
July 5, 2011
Pact will focus on development, manufacturing
Read More »
July 5, 2011
Diagnostic unit gains second commercial clinical test contract.
Read More »
June 30, 2011
Two-year deal covers development services for two candidates
Read More »
June 29, 2011
Florida Biologix to manufacture anti-cancer agent for early trials
Read More »
June 29, 2011
Proteros to add protein crystallization, X-ray structural analysis to AMRI discovery offerings
Read More »
June 29, 2011
Will supply methadone to Ascend
Read More »
June 28, 2011
Joint venture aims to rapidly identify small molecule therapeutics to pharma targets
Read More »
June 28, 2011
Three-year deal will focus on neuroscience candidates
Read More »
376 - 390 of 1089 results
